Five things for pharma marketers to know: Monday, July 17, 2017

Share this content:

1. More Americans are reporting medication errors, according to an analysis of calls made to poison control centers in the U.S. Based on this data, about 400 people have died during a 13-year span due to medication errors. (WaPo)

2. Public Citizen is urging lawmakers to oppose a pair of proposals that would allow drugmakers to engage in some off-label marketing. (The Pharma Letter)

3. Bristol-Myers Squibb launched a new campaign called Ready. Raise. Rise, which seeks to raise awareness about immuno-oncology drugs. It features Eric Stonestreet, an actor from Modern Family, and Dak Prescott, a Dallas Cowboys quarterback.  

4. The latest Senate Health bill is more likely to negatively impact people with pre-existing conditions such as cancer, asthma, and diabetes than an earlier version of the proposed legislation. (Kaiser Health News)

5. Novartis is making a play to market cheaper versions of the world's top arthritis drugs. Last month it received approval to market a biosimilar version of Amgen's Enbrel in the European Union. It also planning to submit applications for Johnson & Johnson's Remicade and AbbVie's Humira this year. (Reuters)

Share this content:
Scroll down to see the next article